Eyestem
News and Trends
Eyestem Research Raises USD 10 Million
The company will use the funding to advance its retinal pigment epithelial (RPE) cell therapy with others
News and Trends
Eyestem Secures Funding to Advance Eyecyte-RPE Phase 2 Clinical Trial
The proceeds will be directed towards completing the ongoing Phase 2 clinical trial of its retinal pigment epithelial cell therapy, Eyecyte-RPE™, in India and preparing for an Investigational New Drug application with the United States Food and Drug Administration.
News and Trends
Eyestem Raises $6.4 Million In Series A Funding Round
The company's vision is to develop a scalable cell therapy platform to treat incurable diseases and democratize access to these newer technologies globally